{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T20:15:53Z","timestamp":1783023353459,"version":"3.54.6"},"reference-count":10,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T00:00:00Z","timestamp":1759449600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["ascpt.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Clin Pharma and Therapeutics"],"published-print":{"date-parts":[[2026,1]]},"abstract":"<jats:p>Pathologic myopia represents a global public health concern, with increasing prevalence and vision loss risk. Myopia typically develops in childhood and progresses more rapidly with earlier onset. Clinical trials exploring treatments for decelerating myopia progression are underway. In Japan, 0.025% atropine ophthalmic solution (RYJUSEA\u00ae) has been approved. This review outlines the evaluation process by the Pharmaceuticals and Medical Devices Agency (PMDA) and highlights challenges for future drug development.<\/jats:p>","DOI":"10.1002\/cpt.70086","type":"journal-article","created":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T07:33:01Z","timestamp":1759476781000},"page":"26-29","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Perspective of the Pharmaceuticals and Medical Devices Agency on Drug Development for Childhood Myopia"],"prefix":"10.1002","volume":"119","author":[{"given":"Mitsuru","family":"Arima","sequence":"first","affiliation":[{"name":"Office of New Drug III, Pharmaceuticals and Medical Device Agency  Tokyo Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Motomasa","family":"Atsumi","sequence":"additional","affiliation":[{"name":"Office of New Drug III, Pharmaceuticals and Medical Device Agency  Tokyo Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kumiko","family":"Takeuchi","sequence":"additional","affiliation":[{"name":"Office of New Drug III, Pharmaceuticals and Medical Device Agency  Tokyo Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takumi","family":"Aoki","sequence":"additional","affiliation":[{"name":"Office of New Drug III, Pharmaceuticals and Medical Device Agency  Tokyo Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emi","family":"Inagaki","sequence":"additional","affiliation":[{"name":"Office of New Drug III, Pharmaceuticals and Medical Device Agency  Tokyo Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yosuke","family":"Kobayashi","sequence":"additional","affiliation":[{"name":"Office of New Drug III, Pharmaceuticals and Medical Device Agency  Tokyo Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takuya","family":"Kageyama","sequence":"additional","affiliation":[{"name":"Office of New Drug III, Pharmaceuticals and Medical Device Agency  Tokyo Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuki","family":"Izumi","sequence":"additional","affiliation":[{"name":"Office of New Drug III, Pharmaceuticals and Medical Device Agency  Tokyo Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsushi","family":"Yoshimura","sequence":"additional","affiliation":[{"name":"Office of New Drug III, Pharmaceuticals and Medical Device Agency  Tokyo Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wataru","family":"Asakura","sequence":"additional","affiliation":[{"name":"Office of New Drug III, Pharmaceuticals and Medical Device Agency  Tokyo Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2025,10,3]]},"reference":[{"key":"e_1_2_10_1_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2018.05.029"},{"key":"e_1_2_10_2_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10384-018-0608-3"},{"key":"e_1_2_10_3_1","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.18-25955"},{"key":"e_1_2_10_4_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamaophthalmol.2021.5067"},{"key":"e_1_2_10_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2021.04.032"},{"key":"e_1_2_10_6_1","unstructured":"Japanese Myopia Society<https:\/\/www.myopiasociety.jp\/general\/about\/>. Accessed July 22 2025."},{"key":"e_1_2_10_7_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41433-023-02722-6"},{"key":"e_1_2_10_8_1","unstructured":"International conference on harmonisation.ICH harmonised tripartite guideline: statistical principles for clinical trials E9<https:\/\/database.ich.org\/sites\/default\/files\/E9_Guideline.pdf> (1998). Accessed July 22 2025."},{"key":"e_1_2_10_9_1","unstructured":"International conference on harmonisation.ICH harmonised tripartite guideline: choice of control group and related issues in clinical trials E10<https:\/\/database.ich.org\/sites\/default\/files\/E10_Guideline.pdf> (1998). Accessed July 22 2025."},{"key":"e_1_2_10_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.xops.2025.100729"}],"container-title":["Clinical Pharmacology &amp; Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ascpt.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/cpt.70086","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T10:36:30Z","timestamp":1767004590000},"score":1,"resource":{"primary":{"URL":"https:\/\/ascpt.onlinelibrary.wiley.com\/doi\/10.1002\/cpt.70086"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,3]]},"references-count":10,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["10.1002\/cpt.70086"],"URL":"https:\/\/doi.org\/10.1002\/cpt.70086","archive":["Portico"],"relation":{},"ISSN":["0009-9236","1532-6535"],"issn-type":[{"value":"0009-9236","type":"print"},{"value":"1532-6535","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,3]]},"assertion":[{"value":"2025-06-07","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-09-02","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-10-03","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}